Picture of Kang Stem Biotech Co logo

217730 Kang Stem Biotech Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual cashflow statement for Kang Stem Biotech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsARSARSAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-21,827-20,176-23,221-7,990-10,467
Depreciation
Amortisation
Non-Cash Items4536951,097-7,428-7,310
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital506-3,2541,711-6,7953,737
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-16,994-18,864-16,498-18,987-11,676
Capital Expenditures-4,650-847-1,409-593-661
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-20,12517,083-89515,607-23,654
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-24,77516,236-2,30415,014-24,315
Financing Cash Flow Items-0.005-61.200.099-49.6
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities39,286-23119,97788435,193
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-2,427-2,8611,175-3,089-797